Stay updated with breaking news from Webinar egnyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
09.10.21 -- Prefilled Syringes: Best Practices In Container Closure Integrity pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.
02.10.21 AI And Machine Learning Prepare Pharma For The Data Onslaught
With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!
By Ed Miseta, chief editor, Clinical Leader When I reached out to several clinical executives in my network for their thoughts on trends that will impact trials in the coming year, the two mentioned most frequently were AI and decentralized trials. ....
01.13.21 #NoGoingBack Supports Keeping Patients First
The Business Of Biotech Cell & Gene Miniseries opens with Dr. Carsten Brunn, president and CEO of Selecta Biosciences. Guest host Erin Harris joins our discussion on Selecta s ImmTOR platform and how the company is addressing the immunogenicity of adeno-associated virus (AAV) vectors challenge faced by gene therapy companies. Listen now and subscribe so you never miss an episode. Featured Editorial By Ed Miseta, chief editor, Clinical Leader #NoGoingBack has been gaining a lot of attention of late. Founded by Signant Health and supported (and chaired) by industry leaders such as Craig Lipset of Clinical Innovation Partners and Allyson Small of SCRS, the group has been pushing for permanent adoption of the trial changes implemented in 2020 to keep patients safe from COVID-19 and drive often-discussed innovation into standard trial practice. ....